Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BM.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.357NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.530NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20229.7US
BA.1.17.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.570NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.633NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.136NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAYNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAENSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.467NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.484NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.476NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.404NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DJ.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.73NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
XAKNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.501NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.226NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.546NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.194NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.429.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.9 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.25.1.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.203NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.157NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.176NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.3.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.391NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.393NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19361.6US
B.1.432NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.388NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.112NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.274NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-3888.18US
B.1.515NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used